Lifestyle

Prospecs Launches 'Speed Rush 3,' a Running Shoe for Beginners

KIM JUNG YOU
2026-06-10 08:24:57
[Edaily Reporter Kim Jeong-yu] Recently, the sports and fashion industries have been actively developing a variety of products for running enthusiasts. It appears that products are becoming increasingly specialized, catering to everyone from beginners to seasoned runners.
Photo: Prospecs

#LS Networks announced on the 10th that its sports brand "Prospecs" has launched the "Speed Rush 3," a shoe designed for beginner runners.

Compared to previous models, this new product features an improved upper structure that provides stable support for the foot during runs. To reduce foot slippage, it incorporates a one-piece tongue and inner padding designed to conform to the shape of the ankle.

The materials have also been upgraded. The midsole uses the company’s proprietary “Superform” foam material to enhance elasticity, and “Airly Tech” technology improves breathability to ensure a comfortable fit during long-distance runs.

A Prospecs representative stated, “The Speed Rush 3 is a product that focuses on structural improvements to reduce tongue curling and foot slippage, incorporating feedback from users of the previous model.” They added, “Based on its secure fit, the elastic propulsion of the Superform midsole, and lightweight feel, we recommend it as a training running shoe that allows beginner runners to maintain their own running routines.”




Economy

Corporation

IT·Science

Economy

Only 8% of Internet Bank Loans Go to Small Business Owners… “The Fourth Internet Bank Should Exceed 50%”

As loans to sole proprietors from the three existing internet-only banks (KakaoBank Corp.(323410), #Kbank, and Toss Bank) remain at around 8% of their total loan portfolio, calls are growing for the f…
2026-08-25 17:44:39

Corporation

Bio Solution Co.,Ltd. Focuses on Managing the “Placebo Group” in DMOAD Trials… What Is the Strategy to Increase the Likelihood of Clinical Success?

Bio Solution Co.,Ltd.(086820)BioSolution is focusing its R&D efforts on clearly demonstrating the difference in efficacy between the treatment group and the placebo group in the clinical trial for “Sp…
2026-08-25 16:20:03